Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
387K
-
Shares change
-
+65.3K
-
Total reported value, excl. options
-
$761K
-
Value change
-
+$151K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$1.97
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q4 2023
16 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q4 2023.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 387K shares
of 29M outstanding shares and own 1.33% of the company stock.
Largest 10 shareholders include Apollon Financial, LLC (200K shares), New Leaf Venture Partners, L.L.C. (97.1K shares), RENAISSANCE TECHNOLOGIES LLC (49.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (17.5K shares), ROYAL BANK OF CANADA (10K shares), MORGAN STANLEY (5.48K shares), UBS Group AG (4.95K shares), WELLS FARGO & COMPANY/MN (1.29K shares), Kelly Financial Services LLC (120 shares), and NewEdge Advisors, LLC (100 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.